Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Proteostasis Therapeutics

This page shows the latest Proteostasis Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Setback for Vertex’s cystic fibrosis challenger Proteostasis

Setback for Vertex’s cystic fibrosis challenger Proteostasis

Unlikely to match market leader's triple therapy. Proteostasis Therapeutics has suffered a major blow to its challenge to Vertex and its portfolio of cystic fibrosis medicines. ... The news sent Proteostasis shares crashing down 63% yesterday - while

Latest news

  • AbbVie and C2N take tau antibody into clinic AbbVie and C2N take tau antibody into clinic

    Other companies working on tau as a target include TauRx Therapeutics, which has a phase III trial ongoing of its lead candidate LTX in Alzheimer's and is due to report ... Meanwhile, Biogen licensed rights to a tau-targeting compound in development at

  • Astellas earmarks up to $1.2bn for protein folding research Astellas earmarks up to $1.2bn for protein folding research

    Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed

  • Elan and Proteostasis partnership

    Elan Corporation has announced it is to partner with Proteostasis Therapeutics on a platform to discover and develop small molecule drugs and diagnostics for the treatment of neurodegenerative disorders. ... There will also be an opportunity for

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for November 2014 Deal Watch table for November 2014

    Company divestment. 1, 530. Proteostasis Therapeutics / Astellas. Therapeutics modulating Unfolded Protein Response - multiple programmes. ... Cerdelga (eliglustat) sold by Vertex. Acquisition 75% royalty stream. 66. Five Prime Therapeutics / BMS.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Proteostasis Therapeutics strengthens leadership team Proteostasis Therapeutics strengthens leadership team

    James DeTore, Geoffrey Gilmartin and Marija Zecevic join. Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments. ... Lastly, Dr Marija Zecevic takes on the role of vice president of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Quick links

Infographics

Multimedia